Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

Literature DB >> 22873829

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

Luana Fianchi, Marianna Criscuolo, Massimo Breccia, Luca Maurillo, Flavia Salvi, Pellegrino Musto, Giovanna Mansueto, Gianluca Gaidano, Carlo Finelli, Antonietta Aloe-Spiriti, Valeria Santini, Mariangelo Greco, Stefan Hohaus, Giuseppe Leone, Maria Teresa Voso.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2012 PMID： 22873829 DOI： 10.3109/10428194.2012.719617

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

Review 1. Chronic myelomonocytic leukemia diagnosis and management.

Authors: Onyee Chan; Aline Renneville; Eric Padron
Journal: Leukemia Date: 2021-03-13 Impact factor: 11.528

Review 2. Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups.

Authors: Francesco Onida; Giovanni Barosi; Giuseppe Leone; Luca Malcovati; Enrica Morra; Valeria Santini; Giorgina Specchia; Sante Tura
Journal: Haematologica Date: 2013-09 Impact factor: 9.941

Review 3. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.

Authors: Kristen B McCullough; Mrinal M Patnaik
Journal: Curr Hematol Malig Rep Date: 2015-09 Impact factor: 3.952

Review 4. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Authors: Mrinal M Patnaik; Ayalew Tefferi
Journal: Am J Hematol Date: 2018-06 Impact factor: 10.047

5. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

Authors: Ana Alfonso; Guillermo Montalban-Bravo; Koichi Takahashi; Elias J Jabbour; Tapan Kadia; Farhad Ravandi; Jorge Cortes; Zeev Estrov; Gautam Borthakur; Naveen Pemmaraju; Marina Konopleva; Carlos Bueso-Ramos; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
Journal: Am J Hematol Date: 2017-05-26 Impact factor: 10.047

Review 6. Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment.

Authors: Hany Elmariah; Amy E DeZern
Journal: Curr Hematol Malig Rep Date: 2019-06 Impact factor: 3.952

7. Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy.

Authors: Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Daniela Piccioni; Paolo de Fabritiis
Journal: Blood Res Date: 2014-03-24

Review 8. Therapy for Chronic Myelomonocytic Leukemia in a New Era.

Authors: Tamara K Moyo; Michael R Savona
Journal: Curr Hematol Malig Rep Date: 2017-10 Impact factor: 3.952

9. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Authors: Piyanuch Kongtim; Uday Popat; Antonio Jimenez; Sameh Gaballa; Riad El Fakih; Gabriela Rondon; Julianne Chen; Carlos Bueso-Ramos; Gautam Borthakur; Naveen Pemmaraju; Guillermo Garcia-Manero; Hagop Kantarjian; Amin Alousi; Chitra Hosing; Paolo Anderlini; Issa F Khouri; Partow Kebriaei; Borje S Andersson; Betul Oran; Katayoun Rezvani; David Marin; Elizabeth J Shpall; Richard E Champlin; Stefan O Ciurea
Journal: Biol Blood Marrow Transplant Date: 2015-09-04 Impact factor: 5.742

Review 10. Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.

Authors: Anthony M Hunter; Ling Zhang; Eric Padron
Journal: Curr Treat Options Oncol Date: 2018-10-27